your badges 52W Range $6–$27 22% of range Analyst Rating BUY 14 analysts Price Target $33 +204% upside P/E -20.6 ROE -21.6% Net Profit Margin ·

CRVS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $10.90
Market Cap (MRQ) $917M
P/E -20.6
EPS $-0.53
ROE -21.6%
52W Range $6–$27

CRVS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
EPS$-0.53
2019-12-31 → 2025-12-31
Free Cash Flow$-33M
2018-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend CRVS 5Y avg Peer Median Verdict
P/E -20.65Y avg ≈-5.2 ≈-5.2 · ·
P/B (MRQ) 4.15Y avg ≈4.9 ≈4.9 4.7 Pricier
Price / FCF (TTM) -20.35Y avg ≈-6.4 ≈-6.4 · ·
Price / Cash Flow (TTM) -20.65Y avg ≈-8.0 ≈-8.0 · ·
Price / Tangible Book 13.35Y avg ≈4.9 ≈4.9 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 46.8%
Next Report Nov 02, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 11, 2026 $-0.19 $-0.16 -17.4%
March 31, 2026 May 6, 2026 $-0.15 $-0.15 -3.0%
Dec. 31, 2025 $-0.15 $-0.13 -13.7%
Sept. 30, 2025 $-0.12 $-0.14 11.8%
June 30, 2025 $-0.10 $-0.14 29.9%
March 31, 2025 $0.21 $-0.12 273.3%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 12
Metric Trend 20252024202320222021202020192018201720162015
R&D Expense $34M$19M$17M$24M$29M$32M$38M$39M$46M$29M$11M
SG&A Expense $9M$8M$7M$8M$10M$12M$11M$11M$10M$8M$2M
Operating Expenses $43M$28M$23M$33M$39M$44M$49M$49M$57M$37M$14M
Operating Income $-43M$-28M$-23M$-33M$-39M$-44M$-49M$-49M$-57M$-37M$-14M
Pretax Income $-13M$-59M$-22M$-31M$-43M$-6M$-47M$-47M$-56M$-36M$-31M
Income Tax $0$0$0$0$0$0$0$0$0$0$0
Net Income $-15M$-62M$-27M$-41M$-43M$-6M$-47M$-47M$-56M$-36M$-31M
EPS (Basic) $-0.19$-1.02$-0.56$-0.89$-1.03$-0.20$-1.59····
EPS (Diluted) $-0.53$-1.02$-0.56$-0.89$-1.03$-0.20$-1.59····
Shares (Basic) 78,964,84260,985,16548,025,27446,553,51141,854,11029,478,87829,349,810····
Shares (Diluted) 79,742,68560,985,16548,025,27446,553,51141,854,11029,478,87829,349,810····
EBITDA $-43M$-27M$-23M$-32M$-38M$-43M$-48M$-48M···
Balance Sheet 23
Metric Trend 20252024202320222021202020192018201720162015
Cash & Equivalents $5M$9M$13M$13M$63M$16M$5M$39M$45M$5M$4M
Receivables $37.0K$75.0K$26.0K$588.0K·······
Prepaid Expense $1M$2M$781.0K$773.0K$1M$1M$1M$992.0K$1M$1M$1M
Other Current Assets $353.0K$548.0K$220.0K$102.0K$128.0K$406.0K$486.0K$265.0K$412.0K$772.0K$208.0K
Current Assets $58M$54M$28M$44M$71M$45M$79M$116M$91M$136M$96M
PP&E (Net) $220.0K$151.0K$236.0K$353.0K$451.0K$906.0K$1M$2M$3M$3M$2M
PP&E (Gross) $3M$5M$5M$5M$5M$5M$5M$5M$4M$4M$2M
Accum. Depreciation $3M$5M$5M$5M$4M$4M$3M$2M$2M$729.0K$135.0K
Other Non-current Assets $855.0K$632.0K$89.0K$129.0K$236.0K$414.0K$513.0K$463.0K$869.0K$869.0K·
Total Assets $71M$69M$46M$68M$109M$86M$84M$118M$95M$140M$98M
Accounts Payable $2M$3M$2M$2M$2M$3M$2M$2M$3M$2M$2M
Accrued Liabilities $6M$4M$4M········
Current Liabilities $9M$35M$7M$11M$10M$12M$10M$7M$9M$6M$3M
Capital Leases $534.0K$937.0K·$1M$3M$1M$2M····
Other Non-current Liabilities ·······$869.0K$971.0K$1M$710.0K
Total Liabilities $10M$36M$7M$12M$12M$13M$13M$8M$10M$7M$4M
Common Stock $7.0K$7.0K$5.0K$5.0K$5.0K$3.0K$3.0K$3.0K$2.0K$2.0K·
Paid-in Capital $474M$431M·········
Retained Earnings $-412M$-397M$-335M$-308M$-266M$-223M$-217M$-170M$-124M$-68M$-31M
AOCI $-896.0K$-1M$-967.0K$-563.0K$2M$4.0K$29.0K$-34.0K$-41.0K$-39.0K$-45.0K
Stockholders' Equity $61M$33M$39M$56M$97M$72M$71M$110M$85M$133M$-31M
Liabilities + Equity $71M$69M$46M$68M$109M$86M$84M$118M$95M$140M$98M
Shares Outstanding 74,696,62967,899,77949,038,58246,553,51146,553,51128,372,63427,953,23329,323,93021,041,25020,922,4281,431,615
Cash Flow 12
Metric Trend 20252024202320222021202020192018201720162015
D&A $105.0K$85.0K$151.0K$367.0K$460.0K$632.0K$743.0K$847.0K$842.0K$594.0K$148.0K
Stock-based Comp $5M$3M$2M$3M$4M$6M$7M$7M$6M$4M$428.0K
Other Non-cash $-23M$34M$796.0K$11M$2M$-35M$1M$-2M···
Operating Cash Flow $-33M$-25M$-24M$-27M$-37M$-35M$-37M$-41M$-46M$-28M$-11M
CapEx $174.0K·$34.0K$269.0K$5.0K$76.0K$25.0K$355.0K$266.0K$2M$2M
Investing Cash Flow $-8M$-27M$16M$-23M$22M$45M$3M$-30M$85M$-43M$-92M
Stock Issued ·$16M··$32M··$65M$711.0K$71M·
Net Stock Activity ·$16M··$32M··$65M···
Financing Cash Flow $36M$49M$8M$0$62M$1M$24.0K$65M$1M$71M$95M
Net Change in Cash $-4M$-4M$-539.0K$-50M$47M$11M$-34M$-6M$40M$945.0K$-8M
Taxes Paid $0··········
Free Cash Flow $-33M·$-24M$-27M$-37M$-35M$-37M$-41M···
Profitability 3
Metric Trend 20252024202320222021202020192018201720162015
ROA -21.8%-108.9%-47.5%-46.5%-44.4%-7.1%-46.2%-44.1%···
ROE -21.6%-277.0%-65.1%-68.4%-42.8%-10.5%-61.6%-41.0%···
ROIC -70.2%-84.6%-60.5%-58.0%-39.8%-60.7%-68.7%-44.6%···
Liquidity & Solvency 2
Metric Trend 20252024202320222021202020192018201720162015
Current Ratio 6.21.54.14.17.43.77.816.4···
Quick Ratio 0.50.21.81.26.51.40.55.6···
Per Share 4
Metric Trend 20252024202320222021202020192018201720162015
Book Value / Share $0.82$0.48$0.79$1.21$2.09$2.54$2.54$3.76···
Cash Flow / Share $-0.41$-0.42$-0.50$-0.58$-0.88······
Cash / Share $0.06$0.13$0.26$0.28$1.36$0.58$0.18$1.34···
EPS (TTM) $-0.53$-1.02$-0.56$-0.89$-1.03$-0.20$-1.59····
Valuation (TTM) 8
Metric Trend 20252024202320222021202020192018201720162015
Net Income TTM $-15M$-62M$-27M$-41M$-43M$-6M$-47M$-47M$-56M$-36M·
Market Cap $575M$363M$86M$40M$112M$101M$152M$108M···
P/E -14.5-5.2-3.1-1.0-2.3-17.8-3.4····
P/B 9.411.22.20.71.21.42.11.0···
P / Tangible Book 9.411.22.20.71.21.4·····
P / Cash Flow -17.5-14.3-3.6-1.5-3.1-2.9-4.1-2.6···
P / FCF -17.4·-3.6-1.4-3.1-2.9-4.1-2.6···
Earnings Yield -6.9%-19.1%-31.8%-104.7%-42.7%-5.6%-29.2%····

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Net Income $-15M $-62M $-27M $-41M $-43M
Diluted EPS $-0.53 $-1.02 $-0.56 $-0.89 $-1.03

Institutional owners (13F) 187 filers · $1.1B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 187
Value held $1.1B
New positions 41
Exited positions 28
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
41 (-28 vs prior Q) 28 (+7 vs prior Q) 72 (+12 vs prior Q) 43 (+14 vs prior Q) +1.0M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
ORBIMED ADVISORS LLC $107,045,190 7,165,006 10.14% Shares
BlackRock, Inc. $106,653,837 7,138,811 10.10% Shares
STATE STREET CORP $66,842,920 4,474,091 6.33% Shares
VANGUARD CAPITAL MANAGEMENT LLC $49,193,087 3,292,710 4.66% Shares
ADAMS STREET PARTNERS LLC $48,937,703 3,275,616 4.63% Shares
Vivo Capital, LLC $41,918,891 2,805,816 3.97% Shares
WELLINGTON MANAGEMENT GROUP LLP $40,810,581 2,731,632 3.87% Shares
PERCEPTIVE ADVISORS LLC $39,851,569 2,667,441 3.77% Shares
Deep Track Capital, LP $37,229,569 2,491,939 3.53% Shares
BRAIDWELL LP $31,766,892 2,126,298 3.01% Shares
VANGUARD GROUP INC $29,825,811 3,873,482 2.82% Shares
GEODE CAPITAL MANAGEMENT, LLC $27,700,900 1,853,659 2.62% Shares
Foresite Capital Management VI LLC $27,358,621 1,831,233 2.59% Shares
GOLDMAN SACHS GROUP INC $23,550,700 1,576,352 2.23% Shares
Hood River Capital Management LLC $23,482,767 1,571,805 2.22% Shares
MORGAN STANLEY $20,090,356 1,344,736 1.90% Shares
Boxer Capital Management, LLC $16,434,000 1,100,000 1.56% Shares
Catalio Capital Management, LP $16,148,467 1,080,888 1.53% Shares
MILLENNIUM MANAGEMENT LLC $15,656,896 1,047,985 1.48% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $12,172,365 814,750 1.15% Shares
TWO SIGMA INVESTMENTS, LP $11,731,008 785,208 1.11% Shares
BANK OF AMERICA CORP /DE/ $11,321,503 757,798 1.07% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $11,205,000 750,000 1.06% Shares
Eversept Partners, LP $11,175,030 747,994 1.06% Shares
EMERALD ADVISERS, LLC $10,244,104 685,683 0.97% Shares
DCF Advisers, LLC $9,524,250 637,500 0.90% Shares
Blue Owl Capital Holdings LP $9,092,484 608,600 0.86% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $8,739,900 585,000 0.83% Call option
NORTHERN TRUST CORP $8,592,861 575,158 0.81% Shares
EMERALD MUTUAL FUND ADVISERS TRUST $7,864,252 526,389 0.74% Shares
VANGUARD FIDUCIARY TRUST CO $7,776,688 520,528 0.74% Shares
RA CAPITAL MANAGEMENT, L.P. $6,723,000 450,000 0.64% Shares
Nextech Invest Ltd. $6,723,000 450,000 0.64% Shares
CITADEL ADVISORS LLC $6,675,192 446,800 0.63% Call option
CITADEL ADVISORS LLC $5,945,388 397,951 0.56% Shares
UBS Group AG $5,917,973 396,116 0.56% Shares
BARCLAYS PLC $4,717,289 315,749 0.45% Shares
Jump Financial, LLC $4,682,196 313,400 0.44% Shares
Trexquant Investment LP $4,427,424 296,347 0.42% Shares
DIADEMA PARTNERS LP $4,404,476 294,811 0.42% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $4,101,030 274,500 0.39% Put option
Polymer Capital Management (HK) LTD $3,939,110 263,662 0.37% Shares
Brevan Howard Capital Management LP $3,739,348 250,291 0.35% Shares
SPHERA FUNDS MANAGEMENT LTD. $3,659,717 244,961 0.35% Shares
Spruce Street Capital LP $3,459,880 231,585 0.33% Shares
SEB Asset Management AB $3,388,938 226,837 0.32% Shares
VICTORY CAPITAL MANAGEMENT INC $3,298,169 220,761 0.31% Shares
Connor, Clark & Lunn Investment Management Ltd. $3,253,185 217,750 0.31% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $3,109,298 208,119 0.29% Shares
Bank of New York Mellon Corp $3,026,973 202,609 0.29% Shares

Show all 187 institutional owners →

Activists & 5%+ owners 5 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Adams Street Partners, LLC, Adams Street 2011 Direct Fund LP, Adams Street 2012 Direct Fund LP, Adams Street 2013 Direct Fund LP, Adams Street 2014 Direct Fund LP, Adams Street 2015 Direct Venture/Growth Fund LP, Adams Street 2016 Direct Venture/Growth Fund LP, Adams Street 2017 Direct Venture/Growth Fund LP, Adams Street 2018 Direct Venture/Growth Fund LP, Adams Street Venture/Growth Fund VI LP ×2 filings Feb. 5, 2026 3.90% Amendment · SEC
ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×13 filings Jan. 27, 2026 10.30% Amendment · SEC
Novo Holdings A/S ×2 filings July 9, 2020 · Initial filing · SEC
Novo Holdings A/S (formerly known as Novo A/S) Jan. 31, 2019 · Initial filing · SEC
Novo A/S March 30, 2016 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 23 insiders · 9 officers · 12 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Richard A Miller MD President and CEO May 18, 2026 P 1,195,035 2 0 $83,453
Leiv Lea Chief Financial Officer Dec. 4, 2025 A 133,238 0 0 $0
Jeffrey Arcara Chief Business Officer Dec. 4, 2025 A · 0 0 $0
William Benton Jones SVP, Pharmaceutical Development Dec. 4, 2025 A 173,130 0 0 $0
Mehrdad Mobasher SVP, Chief Medical Officer Dec. 16, 2020 A · 0 0 $0
Daniel W. Hunt SVP, Chief Business Officer Dec. 12, 2019 A · 0 0 $0
Erik J. Verner VP, Chemistry Research Dec. 12, 2019 A · 0 0 $0
Joseph J Buggy EVP, Discovery Research Dec. 12, 2019 A · 0 0 $0
Jason V Coloma SVP, Chief Business Officer June 8, 2016 A · 0 0 $0
David Scott Moore Director June 11, 2026 A 21,700 1 0 $250,201
Richard Van Den Broek Director June 11, 2026 A · 0 0 $0
Linda S Grais Director June 11, 2026 A 10,000 0 0 $0
Peter A. Thompson Director June 11, 2026 A 210,000 0 0 $0
Ian T Clark Director June 11, 2026 A · 0 0 $0
Andrew C. Chan Director April 23, 2026 A · 0 0 $0
Scott W Morrison Director June 12, 2025 A · 0 0 $0
Terry P Gould Director June 13, 2024 A 126,806 0 0 $0
Edith P. Mitchell Director Dec. 6, 2023 A · 0 0 $0
Steve E. Krognes Director June 9, 2020 A · 0 0 $0
ORBIMED ADVISORS LLC Director March 29, 2016 C 5,258,450 0 0 $0
Adams Street Partners, LLC 10% owner Aug. 11, 2022 A 126,806 0 0 $0
EcoR1 Capital, LLC 10% owner Oct. 1, 2021 S 81,077 0 0 $0
Novo Holdings A/S 10% owner July 8, 2020 S 1,389,498 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 28 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IDNA · iShares Trust 0.79% 156,836 SH Sept. 11, 2026 Daily
BBC · ETFis Series Trust I 0.74% 26,054 NS July 31, 2026 N-PORT
LABU · Direxion Shares ETF Trust 0.27% 99,617 NS July 31, 2026 N-PORT
IWC · iShares Trust 0.21% 230,273 SH Sept. 11, 2026 Daily
VFMO · VANGUARD WELLINGTON FUND 0.12% 156,977 SH Aug. 19, 2026 Daily
PWS · Pacer Funds Trust 0.08% 1,361 NS July 31, 2026 N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust … 0.06% 6,010 SH Oct. 1, 2026 Daily
IBB · iShares Trust 0.06% 481,850 SH Sept. 11, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.06% 72,574 SH Aug. 19, 2026 Daily
IWO · iShares Trust 0.06% 635,860 SH Sept. 11, 2026 Daily
PKW · Invesco Exchange-Traded Fund Trust 0.03% 45,638 SH Oct. 1, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.03% 390,005 SH Aug. 19, 2026 Daily
IWM · iShares Trust 0.03% 1,739,484 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.03% 32,355 NS July 31, 2026 N-PORT
TECB · iShares Trust 0.02% 6,211 SH Sept. 11, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.01% 29,935 NS July 31, 2026 N-PORT
ISCG · iShares Trust 0.01% 7,679 SH Sept. 11, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.01% 844,478 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.01% 189,601 SH Aug. 19, 2026 Daily
WSML · iShares Trust 0.01% 4,491 SH Sept. 11, 2026 Daily
TILT · FlexShares Trust 0.00% 4,266 NS July 31, 2026 N-PORT
ITOT · iShares Trust 0.00% 108,998 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 22,681 SH Sept. 10, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 2,374,106 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 5,593 SH Aug. 19, 2026 Daily
ISCB · iShares Trust · 2,886 SH Sept. 11, 2026 Daily
ISCV · iShares Trust · 8,903 SH Sept. 11, 2026 Daily
SMLF · iShares Trust · 36,191 SH Sept. 11, 2026 Daily

CRVS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 14 analysts BUY
Median target $32.00 +193.6%
5 35.7% Strong Buy
8 57.1% Buy
1 7.1% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

7 analysts · 2026-09-27

Mean target $33.14 +204.1%

← Below all targets Current price $10.90
Low$27.00 Mean$33.14 High$42.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CRVS $575M -14.5 · · -21.6% ·
CGEM $624M -3.2 · · -44.0% ·
KURA $913M -3.3 25.2% -413.0% -116.2% ·
GLUE $1.03B · 63.5% -31.2% -15.4% ·
RIGL $784M 2.2 64.1% 124.7% 155.1% ·
SANA $1.09B -4.2 · · -172.3% ·
JBIO $761M -4.8 · · -47.7% ·
OBX · · · · · ·
ARDX $1.42B -22.4 22.1% -15.1% -40.2% ·

Latest News Recent headlines mentioning this company

23
Is Corvus Pharmaceuticals, Inc. (CRVS) A Good Stock To Buy Now? Yahoo Finance · 3 months, 2 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 6, 2026